全球眼表疾病市场（2023）：研究报告

该报告基于对美国和西欧的眼科医生和验光师的调查（2023年7月），提供了接受眼表疾病检查和测试的患者的趋势、治疗方法的采用状况以及最新信息. 我们编译并提供有关市场趋势的知识等资讯。

我们邀请在 Market-Scope.com 自行註册的大多数专业（白内障、屈光、角膜、青光眼、普通科）的从业者参加我们赞助的年度眼表疾病调查。

研究报告只是对所报告数据的总结分析，并未对整个市场做出任何额外的假设。所有调查资料均经过去识别化处理并储存在安全伺服器上。

分析内容

调查问题由 Market Scope 与调查赞助商合作制定。问题包括但不限于：

• 眼表疾病的类型
• 干眼症的严重程度和病理学
• 过敏性结膜炎的治疗
• 用于评估眼表疾病的诊断剂
• 用于治疗干眼症的眼药水和药物
• 用于干眼症的医疗设备和替代疗法
• 生物製品的使用

Market Scope surveyed ophthalmologists and optometrists in the United States and Western Europe during July 2023 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends.

Practitioners from most specialties (cataract, refractive, cornea, glaucoma, and comprehensive) who self-registered on Market-Scope.com were invited to participate in an annual sponsored survey on ocular surface disease.

An email invitation was sent on July 7, 2023, and last call invitations on July 14 and July 21, 2023. We received 169 total complete, unique responses - 130 from the US and 39 from Western Europe. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey.

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server.

Contents:

Questions included in the survey were developed by Market Scope in combination with companies that sponsor the survey. Question topics included, but were not limited to, the following:

• Types of ocular surface disease prevalence
• Dry eye severity and pathology
• Allergic conjunctivitis treatments
• Diagnostics used to evaluate ocular surface disease
• Drops and pharmaceuticals used to treat dry eye
• Devices and alternative treatments used for dry eye
• Biologics use